Lackluster Response of Rheumatoid Arthritis Patients on Abatacept to Shingrix Vaccine

The chapter examines the suboptimal antibody and cellular responses of rheumatoid arthritis patients on abatacept to the Shingrix vaccine, underscoring the necessity for improved vaccination strategies for this group. It underscores the need for enhancing the vaccine response in patients undergoing abatacept treatment.